Group | No. of children (%) | Positive (%) | Positive rate (95% CI), % | OR (95% CI) | P | ||
---|---|---|---|---|---|---|---|
Total | IFV-A | IFV-B | |||||
Overall | 75,128 | 1486 (100) | 954 (64.20) | 521 (35.06) | 1.98 (1.88–2.01) | ||
Gender | |||||||
Male | 44,961 (59.85) | 882 (59.35) | 580 (60.80) | 295 (56.62) | 1.96 (1.84–2.10) | 1.01 (0.91–1.12) | 0.830a |
Female | 30,167 (40.15) | 604 (40.65) | 374 (39.20) | 226 (43.38) | 2.00 (1.85–2.17) | Reference | |
Age, year | |||||||
< 1 | 26,498 (35.27) | 358 (24.09) | 271 (28.41) | 83 (15.93) | 1.36 (1.22–1.50) | Reference | |
1–2 | 23,919 (31.84) | 536 (36.07) | 361 (37.84) | 174 (33.40) | 2.24 (2.06–2.44) | 1.70 (1.48–1.95) | < 0.001b |
3–5 | 19,207 (25.57) | 426 (28.67) | 251 (26.31) | 172 (33.01) | 2.22 (2.01–2.44) | 1.68 (1.46–1.94) | < 0.001b |
6–17 | 5504 (7.33) | 166 (11.17) | 71 (7.44) | 92 (17.66) | 3.02 (2.58–3.50) | 2.32 (1.92–2.80) | < 0.001b |
Diagnosis | |||||||
URTI | 21,983 (29.26) | 420 (28.26) | 248 (26.00) | 170 (32.63) | 1.91 (1.73–2.10) | Reference | |
LRTI | 53,145 (70.74) | 1066 (71.74) | 706 (74.00) | 351 (67.37) | 2.01 (1.89–2.13) | 1.13 (1.01–1.27) | 0.032c |